ACADIA Pharmaceuticals, Inc. (ACAD)
29.24
-0.49
(-1.65%)
USD |
NASDAQ |
Aug 28, 10:13
ACADIA Pharmaceuticals Cash from Operations (Quarterly) : 100.78M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 100.78M |
| March 31, 2026 | 33.98M |
| December 31, 2025 | -48.73M |
| September 30, 2025 | 74.29M |
| June 30, 2025 | 63.96M |
| March 31, 2025 | 20.32M |
| December 31, 2024 | 40.38M |
| September 30, 2024 | 63.25M |
| June 30, 2024 | 25.01M |
| March 31, 2024 | 29.08M |
| December 31, 2023 | 85.39M |
| September 30, 2023 | -58.96M |
| June 30, 2023 | 8.201M |
| March 31, 2023 | -17.93M |
| December 31, 2022 | -23.85M |
| September 30, 2022 | -0.727M |
| June 30, 2022 | -13.12M |
| March 31, 2022 | -76.33M |
| December 31, 2021 | -23.12M |
| September 30, 2021 | -17.06M |
| June 30, 2021 | -25.33M |
| March 31, 2021 | -60.15M |
| December 31, 2020 | -27.49M |
| September 30, 2020 | -22.79M |
| June 30, 2020 | -36.88M |
| Date | Value |
|---|---|
| March 31, 2020 | -49.00M |
| December 31, 2019 | -29.71M |
| September 30, 2019 | -18.85M |
| June 30, 2019 | -38.40M |
| March 31, 2019 | -64.18M |
| December 31, 2018 | -39.08M |
| September 30, 2018 | -42.28M |
| June 30, 2018 | -40.88M |
| March 31, 2018 | -45.24M |
| December 31, 2017 | -29.90M |
| September 30, 2017 | -58.40M |
| June 30, 2017 | -58.90M |
| March 31, 2017 | -70.56M |
| December 31, 2016 | -63.19M |
| September 30, 2016 | -49.26M |
| June 30, 2016 | -54.74M |
| March 31, 2016 | -41.21M |
| December 31, 2015 | -34.35M |
| September 30, 2015 | -31.85M |
| June 30, 2015 | -29.87M |
| March 31, 2015 | -25.35M |
| December 31, 2014 | -17.80M |
| September 30, 2014 | -17.48M |
| June 30, 2014 | -16.97M |
| March 31, 2014 | -14.18M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Incyte Corp. | 507.66M |
| Agios Pharmaceuticals, Inc. | -57.31M |
| Biogen, Inc. | 448.90M |
| Insmed, Inc. | -88.83M |
| Vertex Pharmaceuticals, Inc. | 1.125B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -8.529M |
| Cash from Financing (Quarterly) | 10.49M |
| Free Cash Flow | 145.62M |
| Free Cash Flow Per Share (Quarterly) | 0.5536 |
| Free Cash Flow to Equity (Quarterly) | 72.63M |
| Free Cash Flow to Firm (Quarterly) | 95.69M |
| Free Cash Flow Yield | 2.90% |